Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2022-12-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to determine the impact on the functional and respiratory outcome of pediatric patients after a stay a PICU of the province of Quebec.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weaning Children From Mechanical Ventilation:Computer-driven System Versus Usual Care
NCT00678912
Comparison Between IMV and SIMV/PS for Ventilatory Support of Children: a Randomized Clinical Trial
NCT00549809
Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure
NCT06899009
Prevention of Reintubation by Using Noninvasive Positive Pressure Ventilation
NCT00977002
Determination of the Optimal Spontaneous Breathing Trial During Weaning of Mechanical Ventilation
NCT04222569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In follow-up PICU clinics, children and family outcomes will be evaluated 2, 6 and 12 months post PICU discharge.Children and their families will be enrolled locally from each PICU, their baseline data will be collected by local research staff and their post-discharge outcomes will be followed centrally from the Centre Hospitalier Universitaire Sainte-Justine.
The specific aims are to determine the functional, respiratory and neurocognitive function of PICU survivors and Health related Quality of life. Psychosocial status of the child and parents will also be determined.
The primary goal is to describe the impact of a critical illness and mechanical ventilation on PICU survivors and their families in order to improve the health and well-being of PICU survivors and their families, and ultimately to improve the care of children after a PICU stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to a PICU at the Centre Hospitalier Universitaire Sainte-Justine (CHUSJ), Montreal Children's Hospital (MCH), Centre Hospitalier Universitaire de Québec - Université Laval (CHUL) or Centre Hospitalier Universitaire de Sherbrooke (CHUS);
* Patients with invasive mechanical ventilation for ≥48 hours.
Exclusion Criteria
1 Day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
OTHER
Laval University
OTHER
St. Justine's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laurence Ducharme-Crevier
Principal Investigator, Pediatric Intensivist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurence Ducharme-Crevier, MD MSc
Role: PRINCIPAL_INVESTIGATOR
St. Justine's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Sainte-Justine
Montreal, Quebec, Canada
Hôpital de Montréal pour enfants (MCH)
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, Canada
Centre Hospitalier Universitaire de Québec - Université Laval (CHUL)
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Patricia Fontela, MD PhD
Role: primary
Jean-Sébastien Tremblay-Roy, MD
Role: primary
Conal Francoeur, MD MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP-21-2022-3571
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.